Trial record 1 of 1 for:    NCT01876446
Previous Study | Return to List | Next Study

Etirinotecan Pegol (NKTR 102) in Treating Patients With Relapsed Small Cell Lung Cancer

This study is currently recruiting participants.
Verified February 2014 by Roswell Park Cancer Institute
Sponsor:
Collaborators:
Nektar Therapeutics
Information provided by (Responsible Party):
Roswell Park Cancer Institute
ClinicalTrials.gov Identifier:
NCT01876446
First received: June 10, 2013
Last updated: February 4, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)